American International Group, Inc. Akouos, Inc. Transaction History

American International Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.46 - $5.2 $29,315 - $61,968	-11,917 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$4.16 - $9.08 $3,490 - $7,618	-839 Reduced 6.58%	11,917 $57,000
Q4 2021 Feb 11, 2022	SELL	$7.65 - $11.38 $2,922 - $4,347	-382 Reduced 2.91%	12,756 $108,000
Q3 2021 Nov 12, 2021	SELL	$9.93 - $13.59 $3,098 - $4,240	-312 Reduced 2.32%	13,138 $153,000
Q2 2021 Aug 13, 2021	SELL	$11.87 - $15.96 $9,780 - $13,151	-824 Reduced 5.77%	13,450 $169,000
Q1 2021 May 07, 2021	BUY	$13.87 - $21.04 $80,931 - $122,768	5,835 Added 69.14%	14,274 $198,000
Q4 2020 Feb 12, 2021	SELL	$17.03 - $22.45 $4,121 - $5,432	-242 Reduced 2.79%	8,439 $167,000
Q3 2020 Nov 04, 2020	BUY	$19.3 - $26.92 $167,543 - $233,692	8,681 New	8,681 $199,000

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.